Evidence of Comparative Efficacy Should Have a Formal Role in European Drug Approvals

BMJ
doi 10.1136/bmj.d4849
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Patient-Reported Outcome Claims in European and United States Orphan Drug Approvals

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies

Oncologist
Cancer ResearchMedicineOncology
2017English

2017 FDA Drug Approvals

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2018English

Regarding “Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies”

Oncologist
Cancer ResearchMedicineOncology
2017English

Telemonitoring Should Have a Central Role in Future Health Care

International Journal of General Medicine
Medicine
2013English

Analysis of Orphan Drug Designations and Approvals in the United States and the European Union

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Should Patients Have a Role in Patient Safety? A Safety Engineering View

Quality and Safety in Health Care
2007English

Orphan Drug Approvals in Europe: Historical Review and Trends

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

FDAs Jumpstart Program: A Vital Tool to Accelerate Drug Approvals

International Journal of ChemTech Research
ChemistryChemical Engineering
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy